Brainstorm Cell Therapeutics (BCLI) Earnings
|
Expand Research on BCLI
| Next EPS Date | 5/10/24 | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -33.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +27.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/10/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/28/24 | Q423 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/14/23 | Q323 | -$0.29 | -$0.15 | -$0.14 | N/A | N/A | N/A |  | | Details | |
| 8/14/23 | Q223 | -$0.27 | -$0.16 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 5/15/23 | Q123 | -$0.14 | -$0.17 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 3/30/23 | Q422 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/14/22 | Q322 | -$0.53 | -$0.18 | -$0.35 | N/A | N/A | N/A | | | Details | |
| 11/14/22 | Q322 | -$0.15 | -$0.17 | +$0.02 | N/A | N/A | N/A | | | Details |
